FMR CORP 13D and 13G filings for Legend Biotech Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:19 am Sale |
2024-12-31 | 13G | Legend Biotech Corporation LEGN |
FMR CORP | 26,614,023 7.300% |
-9,766,415 (-26.85%) |
Filing |
| 2024-11-12 10:32 am Purchase |
2024-11-08 | 13G | Legend Biotech Corporation LEGN |
FMR CORP | 36,380,438 9.999% |
10,784,450 (+42.13%) |
Filing |
| 2024-02-09 09:16 am Sale |
2024-02-08 | 13G | Legend Biotech Corporation LEGN |
FMR CORP | 25,595,988 7.040% |
-7,417,460 (-22.47%) |
Filing |
| 2023-05-10 09:45 am Purchase |
2023-05-09 | 13G | Legend Biotech Corporation LEGN |
FMR CORP | 33,013,448 9.999% |
2,730,292 (+9.02%) |
Filing |
| 2023-02-09 11:18 am Purchase |
2023-02-09 | 13G | Legend Biotech Corporation LEGN |
FMR CORP | 30,283,156 9.227% |
30,283,156 (New Position) |
Filing |